Search Results - "Beleta, J."

Refine Results
  1. 1

    The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D by Mori, F., Pérez-Torres, S., De Caro, R., Porzionato, A., Macchi, V., Beleta, J., Gavaldà, A., Palacios, J.M., Mengod, G.

    Published in Journal of chemical neuroanatomy (01-09-2010)
    “…Phosphodiesterase 4 (PDE4) inhibitors, i.e. rolipram, are being extensively investigated as therapeutic agents in several diseases. Emesis is one of the most…”
    Get full text
    Journal Article
  2. 2

    Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo by Amat, M, Benjamim, C F, Williams, L M, Prats, N, Terricabras, E, Beleta, J, Kunkel, S L, Godessart, N

    Published in British journal of pharmacology (01-11-2006)
    “…Background and purpose: The chemokine receptor CCR1 is a potential target for the treatment of rheumatoid arthritis. To explore the impact of CCR1 blockade in…”
    Get full text
    Journal Article
  3. 3

    Bronchodilator and anti‐inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes by Cortijo, J, Villagrasa, V, Pons, R, Berto, L, Martí‐Cabrera, M, Martinez‐Losa, M, Domenech, T, Beleta, J, Morcillo, E J

    Published in British journal of pharmacology (01-08-1999)
    “…Selective phosphodiesterase 4 (PDE4) inhibitors are of potential interest in the treatment of asthma. We examined the effects of the alkaloid S‐(+)‐glaucine, a…”
    Get full text
    Journal Article
  4. 4

    Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist by Doménech, T, Beleta, J, Palacios, J M

    “…The study of serotonin (5-HT) receptors from the points of view of their anatomical localization and pharmacological characterization has been linked to the…”
    Get full text
    Journal Article
  5. 5

    Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus by Cortijo, J., Bou, J., Beleta, J., Cardelús, I., Llenas, J., Morcillo, E., Gristwood, R.W.

    Published in British journal of pharmacology (01-02-1993)
    “…1 We have investigated the role of cyclic nucleotide phosphodiesterase IV (PDEIV) in the relaxation of human bronchus and guinea‐pig trachea in vitro and in…”
    Get full text
    Journal Article
  6. 6

    Selective induction of cyclo‐oxygenase‐2 activity in the permanent human endothelial cell line HUV‐EC‐C: biochemical and pharmacological characterization by Miralpeix, Montserrat, Camacho, Mercedes, López‐Belmonte, Jesús, Canalías, Francesca, Beleta, Jordi, Ma Palacios, José, Vila, Luis

    Published in British journal of pharmacology (01-05-1997)
    “…Cyclo‐oxygenase (COX), the enzyme responsible for the conversion of arachidonic acid (AA) to prostaglandin H2 (PGH2), exists in two forms, termed COX‐1 and…”
    Get full text
    Journal Article
  7. 7

    Synthesis and biological evaluation of a conformationally free seco-analogue of the immunosuppressant FR901483 by BONJOCH, J, DIABA, F, PUIGBO, G, SOLE, D, SEGARRA, V, SANTAMARIA, L, BELETA, J, RYDER, H, PALACIOS, J.-M

    Published in Bioorganic & medicinal chemistry (01-12-1999)
    “…The synthesis of an azaspirocyclic analogue of FR901483, phosphate 2, is described based on the implementation of a key 5-endo aminocyclization promoted by…”
    Get full text
    Journal Article
  8. 8

    Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors by Palacios, J M, Beleta, J, Segarra, V

    Published in Farmaco (Società chimica italiana : 1989) (01-12-1995)
    “…Second messengers are intracellular substances whose concentration is regulated by the action on their specific receptors of extracellular regulatory molecules…”
    Get more information
    Journal Article
  9. 9

    Resident Cell Chemokine Expression Serves as the Major Mechanism for Leukocyte Recruitment During Local Inflammation by Garcia-Ramallo, Eva, Marques, Teresa, Prats, Neus, Beleta, Jordi, Kunkel, Steven L, Godessart, Nuria

    Published in The Journal of immunology (1950) (01-12-2002)
    “…The mechanistic relationships between initiating stimulus, cellular source and sequence of chemokine expression, and leukocyte recruitment during inflammation…”
    Get full text
    Journal Article
  10. 10

    Studies on the cardiac actions of flosequinan in vitro by Gristwood, R.W., Beleta, J., Bou, J., Cardelús, I., Fernández, A.G., Llenas, J., Berga, P.

    Published in British journal of pharmacology (01-04-1992)
    “…1 We have investigated the in vitro cardiac actions of flosequinan and of its major metabolite in man, BTS 53554. 2 Positive inotropic activity was seen with…”
    Get full text
    Journal Article
  11. 11

    Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species by Doménech, T, Beleta, J, Fernández, A G, Gristwood, R W, Cruz Sánchez, F, Tolosa, E, Palacios, J M

    Published in Brain research. Molecular brain research. (01-01-1994)
    “…Specific binding for the 5-HT4-selective radioligand [3H]GR 113808 has been identified in human and calf brain membranes. Using human tissue the distribution…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones:  A New Class of Orally Active Cyclooxygenase-2 Inhibitors by Caturla, Francisco, Jiménez, Juan-Miguel, Godessart, Núria, Amat, Mercè, Cárdenas, Alvaro, Soca, Lídia, Beleta, Jordi, Ryder, Hamish, Crespo, María I

    Published in Journal of medicinal chemistry (15-07-2004)
    “…A series of 2-phenylpyran-4-ones were prepared and evaluated for their ability to inhibit cyclooxygenase-2 (COX-2). Extensive structure−activity relationship…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Discovery and Characterization of 4'-(2-Furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a Potent, Selective, and Efficacious A sub(2B) Adenosine Receptor Antagonist by Vidal, B, Nueda, A, Esteve, C, Domenech, T, Benito, S, Reinoso, R F, Pont, M, Calbet, M, Lopez, R, Cadavid, MI, Loza, MI, Cirdenas, A, Godessart, N, Beleta, J

    Published in Journal of medicinal chemistry (31-05-2007)
    “…A novel series of N-heteroaryl 4'-(2-furyl)-4,5'-bipyrimidin-2'-aniines has been identified as potent and selective A sub(2B) adenosine receptor antagonists…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine by Bou, Josep, Domènech, Teresa, Puig, Jaume, Heredia, Ascensión, Gras, Jordi, Fernández-Forner, Dolors, Beleta, Jorge, Palacios, José M.

    Published in European journal of pharmacology (20-12-2000)
    “…Almotriptan (3-[2-(dimethylamino)ethyl]-5-(pyrrolidin-1-ylsulfonylmethyl)-1 H-indole) has been studied in several models predictive of activity and selectivity…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Pharmacological Profile of LAS 31180, a New Inotropic/Vasodilator Quinolone Derivative by Gras, Jordi, Cardelûs, Ignasi, Beleta, Jorge, Gristwood, Robert W, Maria Palacios, José, Llenas, Jesús

    Published in Arzneimittel-Forschung (01-11-2000)
    “…Summary LAS 31180 (3-methylsulphonylamino-l-methyl-4(1H)-quinolone, CAS 137338-43-3) was found to have positive inotropic and vasodilator properties through…”
    Get full text
    Journal Article